Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myriad Genetics (MYGN)
:MYGN
Holding MYGN?
Track your performance easily
See the Price Targets and Ratings of:
MYGN Analyst Ratings
Hold
1 Buy
5 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
MYGN Stock 12 Month Forecast
Average Price Target
$19.13
▲(54.40% Upside)
| Highest Price Target$24.00 | Average Price Target$19.13 | Lowest Price Target$13.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
Reiterated
01/15/25
Bank of America Securities
Reiterated
01/15/25
Leerink Partners
Downgraded
12/09/24
Morgan Stanley
Reiterated
11/18/24
Scotiabank
Reiterated
11/13/24
Piper Sandler
Reiterated
11/11/24
J.P. Morgan
Reiterated
11/11/24
Stephens
$30
Hold
142.13%
Upside
Reiterated
10/11/24
Stephens reiterates Equal Weight Rating on Myriad Genetics (MYGN)Stephens analyst Mason Carrico reiterated an Equal Weight rating and $30.00 price target on Myriad Genetics (NASDAQ: MYGN).
Wells Fargo
$35
Buy
182.49%
Upside
Reiterated
10/10/24
Myriad Genetics: A Buy Rating Amid Reaffirmed Strategy and Growth Potential
Wolfe Research
$30→$40
Buy
222.84%
Upside
Reiterated
08/21/24
Myriad Genetics (MYGN) PT Raised to $40 at Wolfe ResearchWolfe Research analyst Doug Schenkel raised the price target on Myriad Genetics (NASDAQ: MYGN) to $40.00 (from $30.00) while maintaining a Outperform rating.
Guggenheim
$25→$29
Buy
134.06%
Upside
Reiterated
08/07/24
Myriad Genetics price target raised to $29 from $25 at GuggenheimMyriad Genetics price target raised to $29 from $25 at Guggenheim
Jefferies
$25→$20
Sell
61.42%
Upside
Downgraded
06/03/24
Myriad Genetics assumed with Underperform from Hold at JefferiesMyriad Genetics assumed with Underperform from Hold at Jefferies
Raymond James
$25→$28
Buy
125.99%
Upside
Reiterated
02/28/24
Myriad Genetics price target raised to $28 from $25 at Raymond JamesMyriad Genetics price target raised to $28 from $25 at Raymond James
Best Analysts Covering Myriad Genetics
Which Analyst Should I Follow If I Want to Buy MYGN and Sell After:
1 Month
xxx
Success Rate
6/8 ratings generated profit
Average Return
+9.88%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +9.88% per trade.
3 Months
xxx
Success Rate
4/8 ratings generated profit
Average Return
+8.36%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +8.36% per trade.
1 Year
Success Rate
5/8 ratings generated profit
Average Return
+2.11%
reiterated a sell rating 2 months ago
Copying Rachel Vatnsdal's trades and holding each position for 1 Year would result in 62.50% of your transactions generating a profit, with an average return of +2.11% per trade.
2 Years
xxx
Success Rate
8/8 ratings generated profit
Average Return
+29.13%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.13% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
MYGN Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
2
4
4
2
Buy
7
9
3
2
0
Hold
5
6
7
8
7
Sell
2
4
3
4
3
Strong Sell
0
0
0
0
0
total
14
21
17
18
12
Each month's total comprises the sum of three months' worth of ratings.
MYGN Financial Forecast
MYGN Stock Forecast FAQ
What is MYGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Myriad Genetics’s 12-month average price target is $19.13.
What is MYGN’s upside potential, based on the analysts’ average price target?
Myriad Genetics has 54.40% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is MYGN a Buy, Sell or Hold?
Myriad Genetics has a consensus rating of Hold which is based on 1 buy ratings, 5 hold ratings and 2 sell ratings.
What is Myriad Genetics’s price target?
The average price target for Myriad Genetics is $19.13. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $24.00 ,the lowest forecast is $13.00. The average price target represents 54.40% Increase from the current price of $12.39.
The highest analyst price target is $24.00 ,the lowest forecast is $13.00. The average price target represents 54.40% Increase from the current price of $12.39.
What do analysts say about Myriad Genetics?
Myriad Genetics’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.
How can I buy shares of MYGN?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.